PTH induced osteoblast Slit3 to decrease aberrant sensory innervation in degenerated vertebral endplates to relieve...

Area of Science:

• Orthopedics
• Neuroscience
• Endocrinology

Background:

• Spinal degeneration, characterized by vertebral endplate changes, is linked to low back pain (LBP).
• Aberrant sensory innervation contributes to pain during spinal degeneration.

Purpose of the Study:

• To investigate the therapeutic potential of parathyroid hormone (PTH) in mouse models of spinal degeneration and LBP.
• To elucidate the mechanisms underlying PTH's effects on vertebral degeneration and pain.

Main Methods:

• Treatment with PTH in aged, SM/J, and young lumbar spine instability mouse models.
• Quantification of vertebral endplate sclerosis, nerve fiber density (PGP9.5+, CGRP+), and gene expression (Slit3, FoxA2).
• Genetic deletion of PTH type 1 receptor and Slit3 in osteocalcin-expressing cells.

Main Results:

• PTH treatment reduced vertebral endplate sclerosis and improved pain behaviors in all three mouse models.
• PTH decreased aberrant innervation (PGP9.5+, CGRP+) and dorsal root ganglia CGRP expression.
• PTH upregulated Slit3 expression, mediated by FoxA2, and this effect was blocked by genetic deletions.

Conclusions:

• PTH treatment alleviates spinal degeneration and associated pain behaviors in mice.
• PTH acts by stimulating osteoblast Slit3 production, reducing aberrant sensory innervation.
• This study identifies a novel mechanism for PTH in managing LBP related to spinal degeneration.